Nationwide data shows 71.2% treatment success in Vietnam for rifampicin-resistant tuberculosis, suggesting improved outcomes with more short regimens.
During the transition from injectable-containing to all-oral short regimens, nationwide data showed 71.2% RR-TB treatment success in Vietnam. The wider use of STRs and addressing LTFU may further improve outcomes. More robust and better managed long regimens are needed for those not eligible for any STR.
No takes yet. Share an insight, caveat, or question.
Phuong et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: